Neuronal grafts for Huntington's disease

1. Kendall, A.L. et al. Functional integration of striatal allografts in a primate model of Huntington's disease. Nature Med. 4, 727−729 (1998). | Article | PubMed  | ISI | ChemPort |
2. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is unstable in Huntington's disease chromosomes. Cell 72, 971−983 (1993). | PubMed  | ISI |
3. Duyao, M. et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genet. 4, 387−392 (1993). | PubMed  | ISI | ChemPort |
4. Andrew, S.E. et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genet. 4, 398−403 (1993). | PubMed  | ISI | ChemPort |
5. MacDonald, M.E. & Gusella, J.F. Huntington's disease: Translating a CAG repeat into a pathogenic mechanism. Curr. Opin. Neurobiol. 6, 638−643 (1996). | Article | PubMed  | ISI | ChemPort |
6. Strong, T.V. et al. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nature Genet. 5, 259−265 (1993). | PubMed  | ISI | ChemPort |
7. Ferrante, R.J. et al. Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J. Neurosci. 9, 3052−3063 (1997).
8. Mangiarini, L. et al. Exon 1 of the Huntington's disease gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493−506 (1996). | Article | PubMed  | ISI | ChemPort |
9. Davies, S.W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537−548 (1997). | Article | PubMed  | ISI | ChemPort |
10. DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990−1993 (1997). | Article | PubMed  | ISI | ChemPort |
11. Björklund, A. & Stenevi, U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177, 555−560 (1979). | Article | PubMed  | ISI |
12. Lindvall, O. et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science, 247, 574−577 (1990). | PubMed  | ISI | ChemPort |
13. Dunnett, S.B. & Svendsen, C.N. Huntington's disease: animal models and transplantation repair. Curr. Opin. Neurobiol. 3, 790−796 (1993). | Article | PubMed  | ChemPort |
14. Nakao, N., Grasbon-Frodl, E.M., Widner, H. & Brundin, P. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease. Neuroscience 74, 959−970 (1996) | PubMed  | ISI | ChemPort |
15. Kopyov, O.V., Jacques, S., Lieberman, A., Duma, C.M. & Eagle, K.S. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp. Neurol. 149, 97−108 (1998). | Article | PubMed  | ISI | ChemPort |

	Top

	Top